
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1046 | 1042 | 1108 | 1158 | 1283 | 1451 |
Fund Return | 4.6% | 4.21% | 10.79% | 5.02% | 5.1% | 3.79% |
Place in category | 127 | 148 | 91 | 105 | 95 | 28 |
% in Category | 25 | 31 | 16 | 25 | 25 | 12 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UBSLuxEqSICAV USA Growth H FAcc | 2.74B | -3.33 | 9.07 | 12.37 | ||
LU0508198768 | 2.74B | -3.39 | 8.51 | 11.80 | ||
LU0511785726 | 2.74B | -3.56 | 7.40 | 10.65 | ||
LU1923635863 | 2.97B | 10.13 | -3.25 | - | ||
LU2000522420 | 2.97B | 9.31 | -8.75 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU2258443139 | 2.4B | 2.71 | 2.70 | - | ||
NN L Patrimonial Balanced Europeanp | 668.87M | 3.36 | 1.87 | 3.53 | ||
NN L Patrimonial Balanced Europeane | 668.87M | 3.37 | 1.86 | 3.52 | ||
LU1444115874 | 668.87M | 5.25 | 3.88 | 3.47 | ||
LU1744628287 | 502.81M | 3.37 | 1.09 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
UBS (Lux) BFConvert Eurp EUR U-X EUR Inc | LU0415180149 | 18.77 | - | - | |
UBS Lux Equity SICAV - European Opportunity Uncons | LU0549584711 | 17.57 | 43,927.200 | -1.80% | |
UBS(LUX) ES Eurp Hi DivSsEUR U-X-acc | LU0566497789 | 14.21 | - | - | |
UBS Lux Bond SICAV - Convert Global EUR I-X-dist | LU0396332644 | 14.02 | 185.210 | -1.09% | |
Teva Pharmaceutical Finance Netherlands II B.V 7.375% | XS2592804434 | 0.66 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Sell | Strong Buy | Strong Buy |
Summary | Neutral | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review